FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $832,581 | -17.6% | 110,863 | -3.2% | 0.00% | – |
Q2 2023 | $1,010,885 | -10.6% | 114,483 | -37.1% | 0.00% | – |
Q1 2021 | $1,131,000 | -25.6% | 182,107 | -10.7% | 0.00% | – |
Q4 2020 | $1,520,000 | +21.4% | 203,999 | -1.3% | 0.00% | – |
Q3 2020 | $1,252,000 | -30.9% | 206,634 | -4.7% | 0.00% | – |
Q2 2020 | $1,811,000 | +366.8% | 216,860 | +123.6% | 0.00% | – |
Q2 2019 | $388,000 | -21.6% | 96,972 | -5.0% | 0.00% | – |
Q1 2019 | $495,000 | -23.8% | 102,077 | +0.2% | 0.00% | – |
Q4 2018 | $650,000 | -22.3% | 101,857 | -0.2% | 0.00% | – |
Q3 2018 | $837,000 | -20.9% | 102,085 | +0.7% | 0.00% | – |
Q2 2018 | $1,058,000 | – | 101,332 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |